Cargando…
An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization
Developing recombinant proteins as nasal vaccines for inducing systemic and mucosal immunity against respiratory viruses is promising. However, additional adjuvants are required to overcome the low immunogenicity of protein antigens. Here, a self-adjuvanted protein-RNA ribonucleoprotein vaccine was...
Autores principales: | Lam, Joy-Yan, Wong, Wan-Man, Yuen, Chun-Kit, Ng, Yau-Yee, San, Chun-Hin, Yuen, Kwok-Yung, Kok, Kin-Hang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610892/ https://www.ncbi.nlm.nih.gov/pubmed/37896953 http://dx.doi.org/10.3390/vaccines11101550 |
Ejemplares similares
-
A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
por: Lam, Joy-Yan, et al.
Publicado: (2022) -
Loss of orf3b in the circulating SARS-CoV-2 strains
por: Lam, Joy-Yan, et al.
Publicado: (2020) -
An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models
por: Yuen, Chun-Kit, et al.
Publicado: (2023) -
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
por: Yuen, Chun-Kit, et al.
Publicado: (2020) -
Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein
por: Wang, Xiaohui, et al.
Publicado: (2020)